AbbVie Inc. (BKK:ABBV19)

AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of THB 13.35 trillion. The enterprise value is 15.43 trillion.

Market Cap	13.35T
Enterprise Value	15.43T

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.76B

Valuation Ratios

The trailing PE ratio is 110.38 and the forward PE ratio is 17.80.

PE Ratio	110.38
Forward PE	17.80
PS Ratio	7.05
PB Ratio	-2,977.78
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.73, with an EV/FCF ratio of 26.05.

EV / Earnings	127.60
EV / Sales	8.15
EV / EBITDA	16.73
EV / EBIT	24.01
EV / FCF	26.05

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.48
Debt / Equity	n/a
Debt / EBITDA	2.48
Debt / FCF	3.87
Interest Coverage	6.92

Financial Efficiency

Return on equity (ROE) is 112.85% and return on invested capital (ROIC) is 16.70%.

Return on Equity (ROE)	112.85%
Return on Assets (ROA)	8.87%
Return on Invested Capital (ROIC)	16.70%
Return on Capital Employed (ROCE)	20.33%
Revenue Per Employee	34.44M
Profits Per Employee	2.20M
Employee Count	55,000
Asset Turnover	0.42
Inventory Turnover	3.65

Taxes

Income Tax	-24.07B
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	60.40
Average Volume (20 Days)	53,910

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.04

Income Statement

In the last 12 months, AbbVie had revenue of THB 1.89 trillion and earned 120.91 billion in profits. Earnings per share was 68.21.

Revenue	1.89T
Gross Profit	1.35T
Operating Income	643.18B
Pretax Income	98.41B
Net Income	120.91B
EBITDA	911.77B
EBIT	643.18B
Earnings Per Share (EPS)	68.21

Balance Sheet

The company has 210.03 billion in cash and 2.29 trillion in debt, giving a net cash position of -2,082.39 billion.

Cash & Cash Equivalents	210.03B
Total Debt	2.29T
Net Cash	-2,082.39B
Net Cash Per Share	n/a
Equity (Book Value)	-4.48B
Book Value Per Share	-3.36
Working Capital	-341.21B

Cash Flow

In the last 12 months, operating cash flow was 626.26 billion and capital expenditures -33.91 billion, giving a free cash flow of 592.36 billion.

Operating Cash Flow	626.26B
Capital Expenditures	-33.91B
Free Cash Flow	592.36B
FCF Per Share	n/a

Margins

Gross margin is 71.25%, with operating and profit margins of 33.95% and 6.45%.

Gross Margin	71.25%
Operating Margin	33.95%
Pretax Margin	5.19%
Profit Margin	6.45%
EBITDA Margin	48.13%
EBIT Margin	33.95%
FCF Margin	31.27%

Dividends & Yields

AbbVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	301.30%
Buyback Yield	-0.03%
Shareholder Yield	n/a
Earnings Yield	0.91%
FCF Yield	4.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	6